Published in Gut on May 01, 1995
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med (1992) 2.31
Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med (1993) 2.16
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet (1993) 1.82
Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol (1987) 1.33
[Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients]. Gastroenterol Clin Biol (1987) 1.33
N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy (1987) 1.31
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology (1981) 1.25
Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology (1985) 1.23
Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg (1982) 1.19
Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology (1989) 1.13
Endoscopic ligation of esophageal varices. Am J Surg (1990) 1.11
A new endoscopic elastic band ligating device. Gastrointest Endosc (1986) 1.07
[Natural history of esophageal varices in cirrhosis (from origin to rupture)]. Gastroenterol Clin Biol (1988) 1.04
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology (1989) 0.97
Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial. Br J Surg (1989) 0.88
Hepatitis B: transmission and natural history. Gut (1993) 0.86
A comparison of immediate versus delayed endoscopic injection sclerosis of bleeding esophageal varices. Gastrointest Endosc (1986) 0.83
Comparison of three nonsurgical treatments for bleeding esophageal varices. Gastroenterology (1989) 0.83
Comparison of 1% sodium tetradecyl sulfate to a thrombogenic sclerosant cocktail for endoscopic sclerotherapy. Am Surg (1988) 0.81
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Bowel preparation at home: prospective study of adverse effects in elderly people. BMJ (1996) 2.43
Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30
A prognostic model for the prediction of survival in cystic fibrosis. Thorax (1997) 2.10
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet (1993) 1.82
Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology (1985) 1.80
Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology (1991) 1.73
Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial. Gut (2003) 1.70
MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol (2001) 1.60
Assessment of the percutaneous endoscopic gastrostomy feeding tube as part of an integrated approach to enteral feeding. Gut (1992) 1.53
Prospective controlled trial of injection sclerotherapy in patient with cirrhosis and recent variceal haemorrhage. Lancet (1980) 1.51
Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases. Eur J Gastroenterol Hepatol (1998) 1.47
Management of common bile duct stones with a biliary endoprosthesis. Report on 40 cases. Gut (1992) 1.42
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
A prospective randomized study of two sclerotherapy techniques for esophageal varices. Hepatology (1983) 1.25
Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: possible relationships of these changes to the developement of peliosis hepatis and liver tumours. Histopathology (1977) 1.25
Liver damage from long-term methyltestosterone. Lancet (1977) 1.25
Portal hypertension--25 years of progress. Gut (1991) 1.24
A prospective single centre study comparing computed tomography pneumocolon against colonoscopy in the detection of colorectal neoplasms. Gut (2000) 1.18
Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules. Gut (1984) 1.18
Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut (1984) 1.14
Liver biopsy as a day-case procedure: selection and complications in 200 consecutive patients. Br Med J (1980) 1.14
Balloon tamponade in variceal bleeding: use and misuse. BMJ (1989) 1.13
A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology (1986) 1.11
Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut (1994) 1.10
Methylene blue staining: is it really useful in Barrett's esophagus? Gastrointest Endosc (2001) 1.09
Androgen related primary hepatic tumors in non-Fanconi patients. Cancer (1983) 1.08
Self-expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass. Aliment Pharmacol Ther (2004) 1.01
An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J Hepatol (1995) 1.00
Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol (1991) 0.98
Randomised study of endoscopic biliary endoprosthesis versus duct clearance for bileduct stones in high-risk patients. Lancet (1996) 0.98
Management of variceal haemorrhage. BMJ (1994) 0.96
Effects of converting enzyme inhibitor on hepatic blood flow in man. Am J Med (1984) 0.96
Pleural effusions associated with pancreaticopleural fistula. Thorax (1993) 0.93
Injection sclerotherapy for the long-term management of variceal bleeding. World J Surg (1984) 0.93
Thrombin--an effective treatment for gastric variceal haemorrhage. Gut (1994) 0.92
The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy (1997) 0.92
Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy. Gut (1987) 0.92
Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma. Clin Oncol (1981) 0.91
Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn's disease. Clin Radiol (2002) 0.91
Single, total paracentesis for tense ascites: sequential hemodynamic changes and right atrial size. Hepatology (1990) 0.90
Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology (1986) 0.88
Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol (1993) 0.86
Use of fibrin glue (beriplast) in the management of bleeding gastric varices. Endoscopy (2003) 0.86
Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology (1989) 0.86
Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut (1999) 0.86
Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. Gastroenterology (1990) 0.86
Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England. Aliment Pharmacol Ther (2008) 0.85
Effect and mechanism of action of isosorbide-5-mononitrate. Gut (1988) 0.82
Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension. Br J Clin Pharmacol (1984) 0.82
Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances. Radiographics (2000) 0.81
Pathophysiology of portal hypertension. Dig Dis (1992) 0.81
Management of acute variceal haemorrhage. Eur J Gastroenterol Hepatol (2001) 0.81
Liver and biliary problems in cystic fibrosis. Br Med Bull (1992) 0.80
Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond) (1999) 0.79
Prognosis in cystic fibrosis. N Engl J Med (1992) 0.78
The history injection sclerotherapy for esophageal varices. Gastrointest Endosc (1983) 0.77
Neonatal sclerosing cholangitis in two siblings: a category of progressive intrahepatic cholestasis. J Pediatr Gastroenterol Nutr (1993) 0.77
Taking the tension out of the portal system. An approach to the management of portal hypertension in the 1990s. Scand J Gastroenterol Suppl (1990) 0.77
Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis. Br J Clin Pharmacol (1990) 0.76
Impaired natriuretic response to atrial natriuretic peptide in the isolated kidney of rats with experimental cirrhosis. Clin Sci (Lond) (1990) 0.76
Hepatic complications of androgen therapy. Gastroenterology (1977) 0.76
Prophylactic injection sclerotherapy for esophageal varices: a critical appraisal. Gastrointest Endosc (1988) 0.76
Strongyloidiasis. Gut (1994) 0.75
Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Gut (1991) 0.75
Emergency colonoscopy for distal intestinal obstruction syndrome in cystic fibrosis patients. Gut (2002) 0.75
The management of an episode of variceal bleeding. Postgrad Med J (1991) 0.75
Treating the ascites of cirrhosis. BMJ (1988) 0.75
Why use Buscopan during diagnostic upper gastrointestinal endoscopy? Gut (1996) 0.75
Elective sclerotherapy--technique and results. Endoscopy (1986) 0.75
Follow-up study after sclerotherapy. Scand J Gastroenterol Suppl (1984) 0.75
Progressive changes on CT scanning of the liver. Gut (2009) 0.75
Endoscopic sclerotherapy for esophageal varices. Dig Dis Sci (1986) 0.75
A simple method for continuous pericardial drainage. Intensive Care Med (1980) 0.75
[The "Liver" Study Group: portal hypertension]. Z Gastroenterol Verh (1988) 0.75
Metabolic effects of beta-adrenergic receptor blockade in advanced alcoholic cirrhosis. J Hepatol (1993) 0.75
What are the gastrointestinal endoscopic requirements of a cancer centre? Clin Oncol (R Coll Radiol) (2007) 0.75
Sclerotherapy of esophageal varices. Prog Liver Dis (1982) 0.75
How to biopsy the liver. Br J Hosp Med (1980) 0.75
Propranolol and cirrhosis. Lancet (1985) 0.75
Systemic haemodynamic changes in patients with cystic fibrosis with and without chronic liver disease. J Hepatol (1996) 0.75
Alcohol and the liver. Br J Hosp Med (1997) 0.75
An unusual cutaneous-polyposis syndrome stabilized with acitretin. Br J Dermatol (2008) 0.75